Dr. Dominic Moon, MD
Claim this profileArea of expertise
Squamous Cell Carcinoma
Dominic Moon, MD has run 1 trial for Squamous Cell Carcinoma. Some of their research focus areas include:
More about Dominic Moon, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Dominic Moon, MD has experience with
- Intensity-modulated Radiation Therapy (IMRT)
Breakdown of trials Dominic Moon, MD has run
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dominic Moon, MD specialize in?
Dominic Moon, MD focuses on Squamous Cell Carcinoma and other conditions. In particular, much of their work with Squamous Cell Carcinoma has involved Stage I patients, or patients who are Stage III.
Is Dominic Moon, MD currently recruiting for clinical trials?
No, Dominic Moon, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Dominic Moon, MD has studied deeply?
Yes, Dominic Moon, MD has studied treatments such as Intensity-modulated Radiation Therapy (IMRT).
What is the best way to schedule an appointment with Dominic Moon, MD?
Apply for one of the trials that Dominic Moon, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.